Daniel K. Lee

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Columbia University Irving Medical Center(Current)

Daniel K. Lee is an author at Columbia University Irving Medical Center specializing in combination checkpoint therapy, combination chemotherapy, and combination immune checkpoint inhibitor toxicity.

Publications per year

2018–2018

Publications

Clinical efficacy of cabozantinib plus nivolumab (CaboNivo) and CaboNivo plus ipilimumab (CaboNivoIpi) in patients (pts) with chemotherapy-refractory metastatic urothelial carcinoma (mUC) either naïve (n) or refractory (r) to checkpoint inhibitor (CPI).

Rosa Nadal, Amir Mortazavi, Mark N. Stein et al. · Journal of Clinical Oncology · 2018 · 15 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1